Global Pharma Ophthalmic Market Insights and Forecast to 2028

Global Pharma Ophthalmic Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Pharma Ophthalmic Product Introduction
1.2 Market by Type
1.2.1 Global Pharma Ophthalmic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Retinal disorders drugs
1.2.3 Allergic, inflammatory and infective drugs
1.2.4 Glaucoma drugs
1.2.5 Dry eye drugs
1.2.6 Other ophthalmic drugs
1.3 Market by Application
1.3.1 Global Pharma Ophthalmic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Glaucoma
1.3.3 Dry eye syndrome
1.3.4 Retinal diseases
1.3.5 Other ophthalmic indications
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pharma Ophthalmic Sales Estimates and Forecasts 2017-2028
2.2 Global Pharma Ophthalmic Revenue Estimates and Forecasts 2017-2028
2.3 Global Pharma Ophthalmic Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pharma Ophthalmic Sales by Region
2.4.1 Global Pharma Ophthalmic Sales by Region (2017-2022)
2.4.2 Global Sales Pharma Ophthalmic by Region (2023-2028)
2.5 Global Pharma Ophthalmic Revenue by Region
2.5.1 Global Pharma Ophthalmic Revenue by Region (2017-2022)
2.5.2 Global Pharma Ophthalmic Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pharma Ophthalmic Sales by Manufacturers
3.1.1 Global Top Pharma Ophthalmic Manufacturers by Sales (2017-2022)
3.1.2 Global Pharma Ophthalmic Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharma Ophthalmic in 2021
3.2 Global Pharma Ophthalmic Revenue by Manufacturers
3.2.1 Global Pharma Ophthalmic Revenue by Manufacturers (2017-2022)
3.2.2 Global Pharma Ophthalmic Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pharma Ophthalmic Revenue in 2021
3.3 Global Pharma Ophthalmic Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pharma Ophthalmic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pharma Ophthalmic Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pharma Ophthalmic Sales by Type
4.1.1 Global Pharma Ophthalmic Historical Sales by Type (2017-2022)
4.1.2 Global Pharma Ophthalmic Forecasted Sales by Type (2023-2028)
4.1.3 Global Pharma Ophthalmic Sales Market Share by Type (2017-2028)
4.2 Global Pharma Ophthalmic Revenue by Type
4.2.1 Global Pharma Ophthalmic Historical Revenue by Type (2017-2022)
4.2.2 Global Pharma Ophthalmic Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pharma Ophthalmic Revenue Market Share by Type (2017-2028)
4.3 Global Pharma Ophthalmic Price by Type
4.3.1 Global Pharma Ophthalmic Price by Type (2017-2022)
4.3.2 Global Pharma Ophthalmic Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pharma Ophthalmic Sales by Application
5.1.1 Global Pharma Ophthalmic Historical Sales by Application (2017-2022)
5.1.2 Global Pharma Ophthalmic Forecasted Sales by Application (2023-2028)
5.1.3 Global Pharma Ophthalmic Sales Market Share by Application (2017-2028)
5.2 Global Pharma Ophthalmic Revenue by Application
5.2.1 Global Pharma Ophthalmic Historical Revenue by Application (2017-2022)
5.2.2 Global Pharma Ophthalmic Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pharma Ophthalmic Revenue Market Share by Application (2017-2028)
5.3 Global Pharma Ophthalmic Price by Application
5.3.1 Global Pharma Ophthalmic Price by Application (2017-2022)
5.3.2 Global Pharma Ophthalmic Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pharma Ophthalmic Market Size by Type
6.1.1 North America Pharma Ophthalmic Sales by Type (2017-2028)
6.1.2 North America Pharma Ophthalmic Revenue by Type (2017-2028)
6.2 North America Pharma Ophthalmic Market Size by Application
6.2.1 North America Pharma Ophthalmic Sales by Application (2017-2028)
6.2.2 North America Pharma Ophthalmic Revenue by Application (2017-2028)
6.3 North America Pharma Ophthalmic Market Size by Country
6.3.1 North America Pharma Ophthalmic Sales by Country (2017-2028)
6.3.2 North America Pharma Ophthalmic Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pharma Ophthalmic Market Size by Type
7.1.1 Europe Pharma Ophthalmic Sales by Type (2017-2028)
7.1.2 Europe Pharma Ophthalmic Revenue by Type (2017-2028)
7.2 Europe Pharma Ophthalmic Market Size by Application
7.2.1 Europe Pharma Ophthalmic Sales by Application (2017-2028)
7.2.2 Europe Pharma Ophthalmic Revenue by Application (2017-2028)
7.3 Europe Pharma Ophthalmic Market Size by Country
7.3.1 Europe Pharma Ophthalmic Sales by Country (2017-2028)
7.3.2 Europe Pharma Ophthalmic Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pharma Ophthalmic Market Size by Type
8.1.1 Asia Pacific Pharma Ophthalmic Sales by Type (2017-2028)
8.1.2 Asia Pacific Pharma Ophthalmic Revenue by Type (2017-2028)
8.2 Asia Pacific Pharma Ophthalmic Market Size by Application
8.2.1 Asia Pacific Pharma Ophthalmic Sales by Application (2017-2028)
8.2.2 Asia Pacific Pharma Ophthalmic Revenue by Application (2017-2028)
8.3 Asia Pacific Pharma Ophthalmic Market Size by Region
8.3.1 Asia Pacific Pharma Ophthalmic Sales by Region (2017-2028)
8.3.2 Asia Pacific Pharma Ophthalmic Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pharma Ophthalmic Market Size by Type
9.1.1 Latin America Pharma Ophthalmic Sales by Type (2017-2028)
9.1.2 Latin America Pharma Ophthalmic Revenue by Type (2017-2028)
9.2 Latin America Pharma Ophthalmic Market Size by Application
9.2.1 Latin America Pharma Ophthalmic Sales by Application (2017-2028)
9.2.2 Latin America Pharma Ophthalmic Revenue by Application (2017-2028)
9.3 Latin America Pharma Ophthalmic Market Size by Country
9.3.1 Latin America Pharma Ophthalmic Sales by Country (2017-2028)
9.3.2 Latin America Pharma Ophthalmic Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pharma Ophthalmic Market Size by Type
10.1.1 Middle East and Africa Pharma Ophthalmic Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pharma Ophthalmic Revenue by Type (2017-2028)
10.2 Middle East and Africa Pharma Ophthalmic Market Size by Application
10.2.1 Middle East and Africa Pharma Ophthalmic Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pharma Ophthalmic Revenue by Application (2017-2028)
10.3 Middle East and Africa Pharma Ophthalmic Market Size by Country
10.3.1 Middle East and Africa Pharma Ophthalmic Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pharma Ophthalmic Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Overview
11.3.3 Roche Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Roche Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Valeant
11.4.1 Valeant Corporation Information
11.4.2 Valeant Overview
11.4.3 Valeant Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Valeant Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Valeant Recent Developments
11.5 Regeneron
11.5.1 Regeneron Corporation Information
11.5.2 Regeneron Overview
11.5.3 Regeneron Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Regeneron Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Regeneron Recent Developments
11.6 Santen
11.6.1 Santen Corporation Information
11.6.2 Santen Overview
11.6.3 Santen Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Santen Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Santen Recent Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Overview
11.7.3 Bayer Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bayer Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Senju
11.9.1 Senju Corporation Information
11.9.2 Senju Overview
11.9.3 Senju Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Senju Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Senju Recent Developments
11.10 Akorn
11.10.1 Akorn Corporation Information
11.10.2 Akorn Overview
11.10.3 Akorn Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Akorn Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Akorn Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pharma Ophthalmic Industry Chain Analysis
12.2 Pharma Ophthalmic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharma Ophthalmic Production Mode & Process
12.4 Pharma Ophthalmic Sales and Marketing
12.4.1 Pharma Ophthalmic Sales Channels
12.4.2 Pharma Ophthalmic Distributors
12.5 Pharma Ophthalmic Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pharma Ophthalmic Industry Trends
13.2 Pharma Ophthalmic Market Drivers
13.3 Pharma Ophthalmic Market Challenges
13.4 Pharma Ophthalmic Market Restraints
14 Key Findings in The Global Pharma Ophthalmic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Pharma Ophthalmic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Retinal disorders drugs
Table 3. Major Manufacturers of Allergic, inflammatory and infective drugs
Table 4. Major Manufacturers of Glaucoma drugs
Table 5. Major Manufacturers of Dry eye drugs
Table 6. Major Manufacturers of Other ophthalmic drugs
Table 7. Global Pharma Ophthalmic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Pharma Ophthalmic Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Pharma Ophthalmic Sales by Region (2017-2022) & (K Pcs)
Table 10. Global Pharma Ophthalmic Sales Market Share by Region (2017-2022)
Table 11. Global Pharma Ophthalmic Sales by Region (2023-2028) & (K Pcs)
Table 12. Global Pharma Ophthalmic Sales Market Share by Region (2023-2028)
Table 13. Global Pharma Ophthalmic Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Pharma Ophthalmic Revenue Market Share by Region (2017-2022)
Table 15. Global Pharma Ophthalmic Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Pharma Ophthalmic Revenue Market Share by Region (2023-2028)
Table 17. Global Pharma Ophthalmic Sales by Manufacturers (2017-2022) & (K Pcs)
Table 18. Global Pharma Ophthalmic Sales Share by Manufacturers (2017-2022)
Table 19. Global Pharma Ophthalmic Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Pharma Ophthalmic Revenue Share by Manufacturers (2017-2022)
Table 21. Pharma Ophthalmic Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 22. Global Pharma Ophthalmic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Pharma Ophthalmic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Ophthalmic as of 2021)
Table 24. Pharma Ophthalmic Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Pharma Ophthalmic Product Offered
Table 26. Date of Manufacturers Enter into Pharma Ophthalmic Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Pharma Ophthalmic Sales by Type (2017-2022) & (K Pcs)
Table 29. Global Pharma Ophthalmic Sales by Type (2023-2028) & (K Pcs)
Table 30. Global Pharma Ophthalmic Sales Share by Type (2017-2022)
Table 31. Global Pharma Ophthalmic Sales Share by Type (2023-2028)
Table 32. Global Pharma Ophthalmic Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Pharma Ophthalmic Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Pharma Ophthalmic Revenue Share by Type (2017-2022)
Table 35. Global Pharma Ophthalmic Revenue Share by Type (2023-2028)
Table 36. Pharma Ophthalmic Price by Type (2017-2022) & (USD/Pcs)
Table 37. Global Pharma Ophthalmic Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 38. Global Pharma Ophthalmic Sales by Application (2017-2022) & (K Pcs)
Table 39. Global Pharma Ophthalmic Sales by Application (2023-2028) & (K Pcs)
Table 40. Global Pharma Ophthalmic Sales Share by Application (2017-2022)
Table 41. Global Pharma Ophthalmic Sales Share by Application (2023-2028)
Table 42. Global Pharma Ophthalmic Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Pharma Ophthalmic Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Pharma Ophthalmic Revenue Share by Application (2017-2022)
Table 45. Global Pharma Ophthalmic Revenue Share by Application (2023-2028)
Table 46. Pharma Ophthalmic Price by Application (2017-2022) & (USD/Pcs)
Table 47. Global Pharma Ophthalmic Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 48. North America Pharma Ophthalmic Sales by Type (2017-2022) & (K Pcs)
Table 49. North America Pharma Ophthalmic Sales by Type (2023-2028) & (K Pcs)
Table 50. North America Pharma Ophthalmic Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Pharma Ophthalmic Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Pharma Ophthalmic Sales by Application (2017-2022) & (K Pcs)
Table 53. North America Pharma Ophthalmic Sales by Application (2023-2028) & (K Pcs)
Table 54. North America Pharma Ophthalmic Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Pharma Ophthalmic Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Pharma Ophthalmic Sales by Country (2017-2022) & (K Pcs)
Table 57. North America Pharma Ophthalmic Sales by Country (2023-2028) & (K Pcs)
Table 58. North America Pharma Ophthalmic Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Pharma Ophthalmic Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Pharma Ophthalmic Sales by Type (2017-2022) & (K Pcs)
Table 61. Europe Pharma Ophthalmic Sales by Type (2023-2028) & (K Pcs)
Table 62. Europe Pharma Ophthalmic Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Pharma Ophthalmic Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Pharma Ophthalmic Sales by Application (2017-2022) & (K Pcs)
Table 65. Europe Pharma Ophthalmic Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Pharma Ophthalmic Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Pharma Ophthalmic Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Pharma Ophthalmic Sales by Country (2017-2022) & (K Pcs)
Table 69. Europe Pharma Ophthalmic Sales by Country (2023-2028) & (K Pcs)
Table 70. Europe Pharma Ophthalmic Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Pharma Ophthalmic Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Pharma Ophthalmic Sales by Type (2017-2022) & (K Pcs)
Table 73. Asia Pacific Pharma Ophthalmic Sales by Type (2023-2028) & (K Pcs)
Table 74. Asia Pacific Pharma Ophthalmic Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Pharma Ophthalmic Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Pharma Ophthalmic Sales by Application (2017-2022) & (K Pcs)
Table 77. Asia Pacific Pharma Ophthalmic Sales by Application (2023-2028) & (K Pcs)
Table 78. Asia Pacific Pharma Ophthalmic Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Pharma Ophthalmic Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Pharma Ophthalmic Sales by Region (2017-2022) & (K Pcs)
Table 81. Asia Pacific Pharma Ophthalmic Sales by Region (2023-2028) & (K Pcs)
Table 82. Asia Pacific Pharma Ophthalmic Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Pharma Ophthalmic Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Pharma Ophthalmic Sales by Type (2017-2022) & (K Pcs)
Table 85. Latin America Pharma Ophthalmic Sales by Type (2023-2028) & (K Pcs)
Table 86. Latin America Pharma Ophthalmic Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Pharma Ophthalmic Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Pharma Ophthalmic Sales by Application (2017-2022) & (K Pcs)
Table 89. Latin America Pharma Ophthalmic Sales by Application (2023-2028) & (K Pcs)
Table 90. Latin America Pharma Ophthalmic Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Pharma Ophthalmic Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Pharma Ophthalmic Sales by Country (2017-2022) & (K Pcs)
Table 93. Latin America Pharma Ophthalmic Sales by Country (2023-2028) & (K Pcs)
Table 94. Latin America Pharma Ophthalmic Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Pharma Ophthalmic Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Pharma Ophthalmic Sales by Type (2017-2022) & (K Pcs)
Table 97. Middle East and Africa Pharma Ophthalmic Sales by Type (2023-2028) & (K Pcs)
Table 98. Middle East and Africa Pharma Ophthalmic Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Pharma Ophthalmic Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Pharma Ophthalmic Sales by Application (2017-2022) & (K Pcs)
Table 101. Middle East and Africa Pharma Ophthalmic Sales by Application (2023-2028) & (K Pcs)
Table 102. Middle East and Africa Pharma Ophthalmic Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Pharma Ophthalmic Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Pharma Ophthalmic Sales by Country (2017-2022) & (K Pcs)
Table 105. Middle East and Africa Pharma Ophthalmic Sales by Country (2023-2028) & (K Pcs)
Table 106. Middle East and Africa Pharma Ophthalmic Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Pharma Ophthalmic Revenue by Country (2023-2028) & (US$ Million)
Table 108. Novartis Corporation Information
Table 109. Novartis Description and Major Businesses
Table 110. Novartis Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 111. Novartis Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Novartis Recent Developments
Table 113. Allergan Corporation Information
Table 114. Allergan Description and Major Businesses
Table 115. Allergan Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 116. Allergan Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Allergan Recent Developments
Table 118. Roche Corporation Information
Table 119. Roche Description and Major Businesses
Table 120. Roche Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 121. Roche Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Roche Recent Developments
Table 123. Valeant Corporation Information
Table 124. Valeant Description and Major Businesses
Table 125. Valeant Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 126. Valeant Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Valeant Recent Developments
Table 128. Regeneron Corporation Information
Table 129. Regeneron Description and Major Businesses
Table 130. Regeneron Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 131. Regeneron Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Regeneron Recent Developments
Table 133. Santen Corporation Information
Table 134. Santen Description and Major Businesses
Table 135. Santen Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 136. Santen Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Santen Recent Developments
Table 138. Bayer Corporation Information
Table 139. Bayer Description and Major Businesses
Table 140. Bayer Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 141. Bayer Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Bayer Recent Developments
Table 143. Pfizer Corporation Information
Table 144. Pfizer Description and Major Businesses
Table 145. Pfizer Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 146. Pfizer Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Pfizer Recent Developments
Table 148. Senju Corporation Information
Table 149. Senju Description and Major Businesses
Table 150. Senju Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 151. Senju Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Senju Recent Developments
Table 153. Akorn Corporation Information
Table 154. Akorn Description and Major Businesses
Table 155. Akorn Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 156. Akorn Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Akorn Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Pharma Ophthalmic Distributors List
Table 161. Pharma Ophthalmic Customers List
Table 162. Pharma Ophthalmic Market Trends
Table 163. Pharma Ophthalmic Market Drivers
Table 164. Pharma Ophthalmic Market Challenges
Table 165. Pharma Ophthalmic Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Ophthalmic Product Picture
Figure 3. Global Pharma Ophthalmic Market Share by Type in 2021 & 2028
Figure 3. Retinal disorders drugs Product Picture
Figure 4. Allergic, inflammatory and infective drugs Product Picture
Figure 5. Glaucoma drugs Product Picture
Figure 6. Dry eye drugs Product Picture
Figure 7. Other ophthalmic drugs Product Picture
Figure 8. Global Pharma Ophthalmic Market Share by Application in 2021 & 2028
Figure 9. Glaucoma
Figure 10. Dry eye syndrome
Figure 11. Retinal diseases
Figure 12. Other ophthalmic indications
Figure 13. Pharma Ophthalmic Report Years Considered
Figure 14. Global Pharma Ophthalmic Sales 2017-2028 (K Pcs)
Figure 15. Global Pharma Ophthalmic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Pharma Ophthalmic Revenue 2017-2028 (US$ Million)
Figure 17. Global Pharma Ophthalmic Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Pharma Ophthalmic Sales Market Share by Region (2017-2022)
Figure 19. Global Pharma Ophthalmic Sales Market Share by Region (2023-2028)
Figure 20. North America Pharma Ophthalmic Sales YoY (2017-2028) & (K Pcs)
Figure 21. North America Pharma Ophthalmic Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Pharma Ophthalmic Sales YoY (2017-2028) & (K Pcs)
Figure 23. Europe Pharma Ophthalmic Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Pharma Ophthalmic Sales YoY (2017-2028) & (K Pcs)
Figure 25. Asia-Pacific Pharma Ophthalmic Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Pharma Ophthalmic Sales YoY (2017-2028) & (K Pcs)
Figure 27. Latin America Pharma Ophthalmic Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Pharma Ophthalmic Sales YoY (2017-2028) & (K Pcs)
Figure 29. Middle East & Africa Pharma Ophthalmic Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Pharma Ophthalmic Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Pharma Ophthalmic in the World: Market Share by Pharma Ophthalmic Revenue in 2021
Figure 32. Global Pharma Ophthalmic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Pharma Ophthalmic Sales Market Share by Type (2017-2028)
Figure 34. Global Pharma Ophthalmic Revenue Market Share by Type (2017-2028)
Figure 35. Global Pharma Ophthalmic Sales Market Share by Application (2017-2028)
Figure 36. Global Pharma Ophthalmic Revenue Market Share by Application (2017-2028)
Figure 37. North America Pharma Ophthalmic Sales Market Share by Type (2017-2028)
Figure 38. North America Pharma Ophthalmic Revenue Market Share by Type (2017-2028)
Figure 39. North America Pharma Ophthalmic Sales Market Share by Application (2017-2028)
Figure 40. North America Pharma Ophthalmic Revenue Market Share by Application (2017-2028)
Figure 41. North America Pharma Ophthalmic Sales Share by Country (2017-2028)
Figure 42. North America Pharma Ophthalmic Revenue Share by Country (2017-2028)
Figure 43. U.S. Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Pharma Ophthalmic Sales Market Share by Type (2017-2028)
Figure 46. Europe Pharma Ophthalmic Revenue Market Share by Type (2017-2028)
Figure 47. Europe Pharma Ophthalmic Sales Market Share by Application (2017-2028)
Figure 48. Europe Pharma Ophthalmic Revenue Market Share by Application (2017-2028)
Figure 49. Europe Pharma Ophthalmic Sales Share by Country (2017-2028)
Figure 50. Europe Pharma Ophthalmic Revenue Share by Country (2017-2028)
Figure 51. Germany Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 52. France Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Pharma Ophthalmic Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Pharma Ophthalmic Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Pharma Ophthalmic Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Pharma Ophthalmic Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Pharma Ophthalmic Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Pharma Ophthalmic Revenue Share by Region (2017-2028)
Figure 62. China Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 65. India Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Pharma Ophthalmic Sales Market Share by Type (2017-2028)
Figure 73. Latin America Pharma Ophthalmic Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Pharma Ophthalmic Sales Market Share by Application (2017-2028)
Figure 75. Latin America Pharma Ophthalmic Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Pharma Ophthalmic Sales Share by Country (2017-2028)
Figure 77. Latin America Pharma Ophthalmic Revenue Share by Country (2017-2028)
Figure 78. Mexico Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Pharma Ophthalmic Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Pharma Ophthalmic Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Pharma Ophthalmic Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Pharma Ophthalmic Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Pharma Ophthalmic Revenu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Artificial Tears Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91

Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......

Global Contact Lens Solution Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96

Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......

Global Latanoprost Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......

Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......

Global Dry Eye Syndrome Drugs Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82

The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......

Global Eye Drops & Lubricants Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......

Global Conjunctivitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......

Global Contact Lens Solution Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118

According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......

Global Latanoprost Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs